Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-185519
Filing Date
2017-05-26
Accepted
2017-05-26 16:05:59
Documents
5
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d377184d10ka.htm 10-K/A 24297
2 EX-10.62 d377184dex1062.htm EX-10.62 185858
3 EX-10.65 d377184dex1065.htm EX-10.65 65596
4 EX-31.3 d377184dex313.htm EX-31.3 3240
5 EX-31.4 d377184dex314.htm EX-31.4 3272
  Complete submission text file 0001193125-17-185519.txt   283401
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

EIN.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35238 | Film No.: 17873965
SIC: 2834 Pharmaceutical Preparations